RQP74014 | |
I. Background | |
The particles contain a firefly luciferase gene driven by the human IL-2 promoter (Figure 1). After transduction, activation of the IL-2 signaling pathway in the target cells can be monitored by measuring the luciferase activity. | |
II. Description | |
The IL-2 Promoter Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. | |
III. Introduction | |
Host Cell: | Jurkat |
Expressed gene: | IL-2-Luciferase |
Stability: | 32 passages |
Synonym(s): | IL-2 Promoter reporter, lentivirus reporter, HIV reporter, VSV-G reporter |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | • Screen for activators or inhibitors of IL-2 signaling pathway in transduced target cells • Generation of IL-2 promoter luciferase reporter stable cell line |
IV. Description of Host Cell Line | |
Organism: | Homo sapiens, human |
Tissue: | Peripheral blood |
Disease: | Acute T cell leukemia |
Morphology: | Lymphoblast |
Growth Properties: | Suspension |
Ⅴ. Representative Data | |
Figure 1. Detect Luciferase assay by Promega Bright-Glo Luciferase Assay System. | |
| |
Figure 2. Detect Luciferase assay by Promega Bright-Glo Luciferase Assay System. Jurkat-IL-2 Luciferase Reporter cells were stimulated by Ionomycin, the EC50 was 8.31ng/ml. |